Transplantation Market Research Report Information By Product Type (Tissue Products, Immunosuppressive Drugs, and Preservation Solutions), By Application (Organ Transplantation and Tissue Transplantation), By End User (Hospitals, Transplantation Centers, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Modality

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL TRANSPLANTATION MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Tissue Products

6.3. Immunosuppressive Drugs

6.4. Preservation Solutions

7. GLOBAL TRANSPLANTATION MARKET, BY APPLICATION

7.1. Overview

7.2. Organ Transplantation

7.3. Tissue Transplantation

8. GLOBAL TRANSPLANTATION MARKET, BY END-USER

8.1. Overview

8.2. Hospitals

8.3. Transplantation Centers

8.4. Others

9. GLOBAL TRANSPLANTATION MARKET, BY REGION

9.1. Overview

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.3. Europe

9.3.1. Germany

9.3.2. France

9.3.3. U.K

9.3.4. Italy

9.3.5. Spain

9.3.6. Rest of Europe

9.4. Asia-Pacific

9.4.1. China

9.4.2. India

9.4.3. Japan

9.4.4. South Korea

9.4.5. Australia

9.4.6. Rest of Asia-Pacific

9.5. Rest of the World

9.5.1. Middle East

9.5.2. Africa

9.5.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Transplantation Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Transplantation Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Type Launch/Application Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. Novartis AG (Switzerland)

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Teva Pharmaceutical Industries Ltd. (Israel)

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Arthrex, Inc. (U.S.)

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Veloxis Pharmaceuticals, Inc. (Asahi Kasei Corporation) (U.S.)

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. BioLife Solutions (U.S.)

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. TRANSMEDICS (U.S.).

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. F. Hoffmann-La Roche Ltd (Switzerland)

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Zimmer Biomet (U.S.)

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Astellas Pharma Inc. (Japan).

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL TRANSPLANTATION MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL TRANSPLANTATION MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 GLOBAL TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 8 NORTH AMERICA TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 9 NORTH AMERICA TRANSPLANTATION MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 10 U.S. TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 11 U.S. TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 12 U.S. TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 13 CANADA TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 14 CANADA TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 15 CANADA TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 16 EUROPE TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 17 EUROPE TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 18 EUROPE TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 19 EUROPE TRANSPLANTATION MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 20 GERMANY TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 21 GERMANY TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 22 GERMANY TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 23 FRANCE TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 24 FRANCE TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 25 FRANCE TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 26 ITALY TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 27 ITALY TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 28 ITALY TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 29 SPAIN TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 30 SPAIN TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 31 SPAIN TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 32 U.K TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 33 U.K TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 34 U.K TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 35 REST OF EUROPE TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 36 REST OF EUROPE TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 37 REST OF EUROPE TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 38 ASIA PACIFIC TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 39 ASIA PACIFIC TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 40 ASIA PACIFIC TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 41 ASIA PACIFIC TRANSPLANTATION MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 42 JAPAN TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 43 JAPAN TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 44 JAPAN TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 45 CHINA TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 46 CHINA TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 47 CHINA TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 48 INDIA TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 49 INDIA TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 50 INDIA TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 51 AUSTRALIA TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 52 AUSTRALIA TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 53 AUSTRALIA TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 54 SOUTH KOREA TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 55 SOUTH KOREA TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 56 SOUTH KOREA TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 57 REST OF ASIA-PACIFIC TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 58 REST OF ASIA-PACIFIC TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 59 REST OF ASIA-PACIFIC TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 60 REST OF WORLD TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 61 REST OF WORLD TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 62 REST OF WORLD TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 63 REST OF WORLD TRANSPLANTATION MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 64 MIDDLE EAST TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 65 MIDDLE EAST TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 66 MIDDLE EAST TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 67 AFRICA TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 68 AFRICA TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 69 AFRICA TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 70 LATIN AMERICA TRANSPLANTATION MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 71 LATIN AMERICA TRANSPLANTATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 72 LATIN AMERICA TRANSPLANTATION MARKET, BY END-USER, 2018-2032 (USD BILLION) 

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL TRANSPLANTATION MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL TRANSPLANTATION MARKET

FIGURE 4 GLOBAL TRANSPLANTATION MARKET, SHARE (%), BY PRODUCT TYPE, 2022

FIGURE 5 GLOBAL TRANSPLANTATION MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 6 GLOBAL TRANSPLANTATION MARKET, SHARE (%), BY END-USER, 2022

FIGURE 7 GLOBAL TRANSPLANTATION MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 NORTH AMERICA: TRANSPLANTATION MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 EUROPE: TRANSPLANTATION MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 ASIA-PACIFIC: TRANSPLANTATION MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 REST OF THE WORLD: TRANSPLANTATION MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 GLOBAL TRANSPLANTATION MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 13 NOVARTIS AG (SWITZERLAND): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 NOVARTIS AG (SWITZERLAND): SWOT ANALYSIS

FIGURE 15 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL): SWOT ANALYSIS

FIGURE 17 ARTHREX, INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 ARTHREX, INC. (U.S.): SWOT ANALYSIS

FIGURE 19 VELOXIS PHARMACEUTICALS, INC. (ASAHI KASEI CORPORATION) (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 VELOXIS PHARMACEUTICALS, INC. (ASAHI KASEI CORPORATION) (U.S.): SWOT ANALYSIS

FIGURE 21 BIOLIFE SOLUTIONS (U.S.).: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 BIOLIFE SOLUTIONS (U.S.).: SWOT ANALYSIS

FIGURE 23 TRANSMEDICS (U.S.).: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 TRANSMEDICS (U.S.).: SWOT ANALYSIS

FIGURE 25 F. HOFFMANN-LA ROCHE LTD (SWITZERLAND): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 F. HOFFMANN-LA ROCHE LTD (SWITZERLAND): SWOT ANALYSIS

FIGURE 27 ZIMMER BIOMET (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 ZIMMER BIOMET (U.S.): SWOT ANALYSIS

FIGURE 29 ASTELLAS PHARMA INC. (JAPAN).: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 ASTELLAS PHARMA INC. (JAPAN).: SWOT ANALYSIS